Calvin Kuo
Co-Founder & Member of Scientific AdvisorDr. Calvin Kuo, M.D., Ph.D. serves as Co-Founder and Member of Scientific Advisor at Surrozen, Inc. He serves as Scientific Co-Founder & Member of Scientific Advisory Board at Mozart Therapeutics, Inc. He is a Co-Founder of TOMA Biosciences, Inc. and serves as its Scientific Advisor. Dr. Kuo serves as Professor of Hematology, Department of Medicine, Stanford University School of Medicine. He served as an Associate/Assistant Professor of Medicine in the Hematology of Stanford University School of Medicine since 2001. Dr. Kuo is a leader in the field of cancer biology and is generally considered one of the premier oncological physician-scientists in the world. His research has received numerous large grants from the NIH, NCI and various prestigious private foundations. Dr. Kuo serves as Member of Scientific Advisory Board of Athenagen Inc. and CoMentis, Inc. Dr. Kuo serves as Member of Scientific and Clinical Advisory Board of OncoMed Pharmaceuticals Inc. He served as a Member of Scientific Advisory Board at Silence Therapeutics plc. He is principal investigator on numerous NIH grants. He served as Member of Scientific Advisory Board at Intradigm Corporation. Dr. Kuo has published extensively in journals including Nature, Science, Cell and Nature Medicine and is an inventor on numerous issued and pending patents. He received junior faculty awards from the Burroughs Wellcome and Kimmel Foundations and has been elected to the American Society for Clinical Investigation. Dr. Kuo has the distinction of serving as the Research Committee Chair for the NIH Intestinal Stem Cell Consortium. He has received numerous awards including a Howard Hughes Medical Institute Fellowship, Investigator Awards from the Burroughs Wellcome and Kimmel Foundations. He is consistently named to various NIH study sections and as a reviewer to major medical journals including Nature, Nature Medicine, PNAS and Blood. His insight and creativity have led to numerous important advances in the fields of hematology and oncology, resulting in multiple patent applications, two of which are licensed by this company. He performed postdoctoral research at Harvard Children's Hospital. Dr. Kuo received his A.B. from Harvard College and his M.D. and Ph.D. degree from Stanford University.
Positions
- Company NameSurrozen, Inc.Stock CodeSRZNPositionCo-Founder & Member of Scientific AdvisorColleagues
- CCCraig C. ParkerCEO, President & Director
- DJDavid J. WoodhouseIndependent Chairman of the Board
- CWCharles WilliamsCOO & Corporate Secretary
- YLYang LiExecutive Vice President of Research
- KCK. Christopher GarciaCo-Founder & Member of Scientific Advisory Board
- RNRoeland NusseCo-Founder & Member of Scientific Advisory Board
